COST-EFFECTIVENESS ANALYSIS OF LIPID-MODIFYING THERAPY IN CANADA - COMPARISON OF HMG-COA REDUCTASE INHIBITORS IN THE PRIMARY PREVENTION OF CORONARY HEART-DISEASE

Citation
B. Jolain et D. Pettitt, COST-EFFECTIVENESS ANALYSIS OF LIPID-MODIFYING THERAPY IN CANADA - COMPARISON OF HMG-COA REDUCTASE INHIBITORS IN THE PRIMARY PREVENTION OF CORONARY HEART-DISEASE, Clinical therapeutics, 17(3), 1995, pp. 572-575
Citations number
NO
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
01492918
Volume
17
Issue
3
Year of publication
1995
Pages
572 - 575
Database
ISI
SICI code
0149-2918(1995)17:3<572:CAOLTI>2.0.ZU;2-X